Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 20;60(7):e0009222.
doi: 10.1128/jcm.00092-22. Epub 2022 May 31.

Proceedings of the Clinical Microbiology Open 2018 and 2019 - a Discussion about Emerging Trends, Challenges, and the Future of Clinical Microbiology

Affiliations
Review

Proceedings of the Clinical Microbiology Open 2018 and 2019 - a Discussion about Emerging Trends, Challenges, and the Future of Clinical Microbiology

Christopher D Doern et al. J Clin Microbiol. .

Abstract

Clinical Microbiology Open (CMO), a meeting supported by the American Society for Microbiology's Clinical and Public Health Microbiology Committee (CPHMC) and Corporate Council, provides a unique interactive platform for leaders from diagnostic microbiology laboratories, industry, and federal agencies to discuss the current and future state of the clinical microbiology laboratory. The purpose is to leverage the group's diverse views and expertise to address critical challenges, and discuss potential collaborative opportunities for diagnostic microbiology, through the utilization of varied resources. The first and second CMO meetings were held in 2018 and 2019, respectively. Discussions were focused on the diagnostic potential of innovative technologies and laboratory diagnostic stewardship, including expansion of next-generation sequencing into clinical diagnostics, improvement and advancement of molecular diagnostics, emerging diagnostics, including rapid antimicrobial susceptibility and point of care testing (POCT), harnessing big data through artificial intelligence, and staffing in the clinical microbiology laboratory. Shortly after CMO 2019, the coronavirus disease 2019 (COVID-19) pandemic further highlighted the need for the diagnostic microbiology community to work together to utilize and expand on resources to respond to the pandemic. The issues, challenges, and potential collaborative efforts discussed during the past two CMO meetings proved critical in addressing the COVID-19 response by diagnostic laboratories, industry partners, and federal organizations. Planning for a third CMO (CMO 2022) is underway and will transition from a discussion-based meeting to an action-based meeting. The primary focus will be to reflect on the lessons learned from the COVID-19 pandemic and better prepare for future pandemics.

Keywords: COVID; next-generation sequencing; pandemic; point of care testing; staffing; stewardship; utilization.

PubMed Disclaimer

Conflict of interest statement

The authors declare a conflict of interest. C.D.D. - Quidel Scientific Advisor, Cepheid - Scientific Advisor; S.D. - Luminex Employee.

References

    1. Church DL, Cerutti L, Gurtler A, Griener T, Zelazny A, Emler S. 2020. Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. Clin Microbiol Rev 33:e00053-19. doi:10.1128/CMR.00053-19. - DOI - PMC - PubMed
    1. Administration FaD. 2019. Database for reference grade microbial sequences (FDA-ARGOS). https://www.fda.gov/medical-devices/science-and-research-medical-devices.... Accessed 9/20/2021.
    1. Gargis AS, Kalman L, Lubin IM. 2016. Assuring the quality of next-generation sequencing in clinical microbiology and public health laboratories. J Clin Microbiol 54:2857–2865. doi:10.1128/JCM.00949-16. - DOI - PMC - PubMed
    1. Hutchins RJ, Phan KL, Saboor A, Miller JD, Muehlenbachs A, Workgroup CNQ. 2019. Practical guidance to implementing quality management systems in public health laboratories performing next-generation sequencing: personnel, equipment, and process management (phase 1). J Clin Microbiol 57:e00261-19. doi:10.1128/JCM.00261-19. - DOI - PMC - PubMed
    1. Lepuschitz S, Weinmaier T, Mrazek K, Beisken S, Weinberger J, Posch AE. 2020. Analytical performance validation of next-generation sequencing based clinical microbiology assays using a k-mer analysis workflow. Front Microbiol 11:1883. doi:10.3389/fmicb.2020.01883. - DOI - PMC - PubMed